pubmed-article:15614692 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:15614692 | lifeskim:mentions | umls-concept:C0305065 | lld:lifeskim |
pubmed-article:15614692 | lifeskim:mentions | umls-concept:C0271429 | lld:lifeskim |
pubmed-article:15614692 | lifeskim:mentions | umls-concept:C0042210 | lld:lifeskim |
pubmed-article:15614692 | lifeskim:mentions | umls-concept:C0037088 | lld:lifeskim |
pubmed-article:15614692 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
pubmed-article:15614692 | lifeskim:mentions | umls-concept:C0004083 | lld:lifeskim |
pubmed-article:15614692 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
pubmed-article:15614692 | pubmed:issue | 1 | lld:pubmed |
pubmed-article:15614692 | pubmed:dateCreated | 2004-12-22 | lld:pubmed |
pubmed-article:15614692 | pubmed:abstractText | Clinical symptoms and signs in acute otitis media (AOM) may differ depending on the various pneumococcal serotypes causing the disease. Alteration in clinical presentation of AOM could be expected after wide-scale pneumococcal vaccinations if there were considerable differences between vaccine serotypes and nonvaccine serotypes. | lld:pubmed |
pubmed-article:15614692 | pubmed:language | eng | lld:pubmed |
pubmed-article:15614692 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15614692 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:15614692 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:15614692 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:15614692 | pubmed:month | Jan | lld:pubmed |
pubmed-article:15614692 | pubmed:issn | 1537-6591 | lld:pubmed |
pubmed-article:15614692 | pubmed:author | pubmed-author:LeinonenMaija... | lld:pubmed |
pubmed-article:15614692 | pubmed:author | pubmed-author:KarmaPekkaP | lld:pubmed |
pubmed-article:15614692 | pubmed:author | pubmed-author:KaijalainenTa... | lld:pubmed |
pubmed-article:15614692 | pubmed:author | pubmed-author:PalmuArto A... | lld:pubmed |
pubmed-article:15614692 | pubmed:author | pubmed-author:KilpiTerhi... | lld:pubmed |
pubmed-article:15614692 | pubmed:author | pubmed-author:JokinenJukka... | lld:pubmed |
pubmed-article:15614692 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:15614692 | pubmed:day | 1 | lld:pubmed |
pubmed-article:15614692 | pubmed:volume | 40 | lld:pubmed |
pubmed-article:15614692 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:15614692 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:15614692 | pubmed:pagination | 52-7 | lld:pubmed |
pubmed-article:15614692 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
pubmed-article:15614692 | pubmed:meshHeading | pubmed-meshheading:15614692... | lld:pubmed |
pubmed-article:15614692 | pubmed:meshHeading | pubmed-meshheading:15614692... | lld:pubmed |
pubmed-article:15614692 | pubmed:meshHeading | pubmed-meshheading:15614692... | lld:pubmed |
pubmed-article:15614692 | pubmed:meshHeading | pubmed-meshheading:15614692... | lld:pubmed |
pubmed-article:15614692 | pubmed:meshHeading | pubmed-meshheading:15614692... | lld:pubmed |
pubmed-article:15614692 | pubmed:meshHeading | pubmed-meshheading:15614692... | lld:pubmed |
pubmed-article:15614692 | pubmed:meshHeading | pubmed-meshheading:15614692... | lld:pubmed |
pubmed-article:15614692 | pubmed:meshHeading | pubmed-meshheading:15614692... | lld:pubmed |
pubmed-article:15614692 | pubmed:meshHeading | pubmed-meshheading:15614692... | lld:pubmed |
pubmed-article:15614692 | pubmed:year | 2005 | lld:pubmed |
pubmed-article:15614692 | pubmed:articleTitle | Association of clinical signs and symptoms with pneumococcal acute otitis media by serotype--implications for vaccine effect. | lld:pubmed |
pubmed-article:15614692 | pubmed:affiliation | National Public Health Institute, Helsinki, Finland. arto.palmu@ktl.fi | lld:pubmed |
pubmed-article:15614692 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:15614692 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |